1. miR-382 functions as a tumor suppressor against esophageal squamous cell carcinoma
   Jie Feng et al, 2017, WJG CrossRef
2. CCN2 promotes drug resistance in osteosarcoma by enhancing ABCG2 expression
   Hsiao-Chi Tsai et al, 2018, J Cell Physiol CrossRef
3. Angiogenesis process in osteosarcoma: an updated perspective of pathophysiology and therapeutics
   Yu-sheng Li et al, 2018, The American Journal of the Medical Sciences CrossRef
4. Drug resistance‐related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies
   Ruiling Chen et al, 2019, J Cell Mol Med CrossRef
5. miRNA signatures in childhood sarcomas and their clinical implications
   G. M. Viera et al, 2019, Clin Transl Oncol CrossRef
6. miR-199a-5p Represses Protective Autophagy and Overcomes Chemoresistance by Directly Targeting DRAM1 in Acute Myeloid Leukemia
   Yang Li et al, 2019, Journal of Oncology CrossRef
7. Targeting autophagy in cancer stem cells as an anticancer therapy
   Yuanyuan Lei et al, 2017, Cancer Letters CrossRef
8. Interaction among inflammasome, autophagy and non-coding RNAs: new horizons for drug
   Qinqin Pu et al, 2019 CrossRef
9. Current updates on microRNAs as regulators of chemoresistance
   Metin Çalışkan et al, 2017, Biomedicine & Pharmacotherapy CrossRef
10. Role of miR-199a-5p in osteoblast differentiation by targeting TET2
    Xiang-Bei Qi et al, 2019, Gene CrossRef
11. Insight Into the Role of Autophagy in Osteosarcoma and Its Therapeutic Implication.
    Jianfang Niu et al, 2019, Front Oncol CrossRef
12. CircMUC16 promotes autophagy of epithelial ovarian cancer via interaction with ATG13 and miR-199a
    Xiaoling Gan et al, 2020, Mol Cancer CrossRef
13. Autophagy regulation by microRNAs: Novel insights into osteosarcoma therapy
    Zeinab Jamali et al, 2020, IUBMB Life CrossRef
14. Novel strategies to prevent the development of multidrug resistance (MDR) in cancer.
    Jinglu Wang et al, 2017, Oncotarget CrossRef
15. Noncoding RNA in drug resistant sarcoma
    Xiaoyang Li et al, 2017, Oncotarget CrossRef
16. Overexpression of microRNA‑506‑3p aggravates the injury of vascular endothelial cells in patients with hypertension by downregulating Beclin1 expression
    Fanfan Yi et al, 2018, Exp Ther Med CrossRef
17. Low‑intensity ultrasound enhances the chemosensitivity of hepatocellular carcinoma cells to cisplatin via altering the miR‑34a/c‑Met axis
    Panpan Li et al, 2019, Int J Mol Med CrossRef
18. MicroRNA expression profiles in non‑epithelial ovarian tumors.
    Weng-Onn Lui, 0 CrossRef
19. Targeting autophagy is a promising therapeutic strategy to overcome chemoresistance and reduce metastasis in osteosarcoma
    Yu‑Xin Liao et al, 2019, Int J Oncol CrossRef
20. Downregulation of BAG3 attenuates cisplatin resistance by inhibiting autophagy in human epithelial ovarian cancer cells
    Shuang Qiu et al, 2019, Oncol Lett CrossRef
21. MicroRNA‑504 modulates osteosarcoma cell chemoresistance to cisplatin by targeting p53
    Xin Chen et al, 2018, Oncol Lett CrossRef
22. Autophagy-mediating microRNAs in cancer chemoresistance
    Yuanming Jing et al, 2020, Cell Biol Toxicol CrossRef
23. MicroRNA-mediated autophagy regulation in cancer therapy: The role in chemoresistance/chemosensitivity
    Milad Ashrafizadeh et al, 2020, European Journal of Pharmacology CrossRef
24. Recent Insights into Therapy Resistance in Osteosarcoma
    Zachary D. Prudowsky et al, 2020, Cancers CrossRef
25. Noncoding RNAs in osteosarcoma: Implications for drug resistance
    Zhengjun Lin et al, 2021, Cancer Letters CrossRef
26. Research Progress of MicroRNA in Chemotherapy Resistance of Osteosarcoma
    Zhaopeng Tang et al, 2021, Technol Cancer Res Treat CrossRef
27. Energy metabolism in bone tumors
    Edith Bonnelye, 2022 CrossRef
28. The MicroRNA-Based Strategies to Combat Cancer Chemoresistance via Regulating Autophagy
    Yuhe Lei et al, 2022, Front. Oncol. CrossRef
29. Research Progress of Exosome-Loaded miRNA in Osteosarcoma
    Peng Yao et al, 2022, Cancer Control CrossRef
30. The regulation of autophagy by the miR-199a-5p/p62 axis was a potential mechanism of small cell lung cancer cisplatin resistance
    Tiezhi Li et al, 2022, Cancer Cell Int CrossRef
31. Virus, Exosome, and MicroRNA: New Insights into Autophagy
    Javid Sadri Nahand et al, 2022 CrossRef
32. Non-coding RNAs in drug and radiation resistance of bone and soft-tissue sarcoma: a systematic review
    Huan-Huan Chen et al, 2022 CrossRef
33. Autophagy as a self-digestion signal in human cancers: Regulation by microRNAs in affecting carcinogenesis and therapy response
    Mustafa M. Kadhim et al, 2023, Pharmacological Research CrossRef
34. MicroRNAs as the critical regulators of autophagy-mediated cisplatin response in tumor cells
    Faezeh Tolue Ghasaban et al, 2023, Cancer Cell Int CrossRef
35. MicroRNAs as the pivotal regulators of cisplatin resistance in osteosarcoma
    Meysam Moghbeli, 2023, Pathology - Research and Practice CrossRef
36. Autophagy-driven regulation of cisplatin response in human cancers: Exploring molecular and cell death dynamics
    Yang Yang et al, 2024, Cancer Letters CrossRef
37. Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA
    Hefen Chen et al, 2024, Drug Development Research CrossRef
38. MicroRNA-mediated autophagy and drug resistance in cancer: mechanisms and therapeutic strategies
    Jinxing Wei et al, 2024, Discov Onc CrossRef
39. Harnessing luciferase chemistry in regulated cell death modalities and autophagy: overview and perspectives
    Saman Hosseinkhani et al, 2024, Chem. Soc. Rev. CrossRef